Skip to contentB
Bioadaptives, Inc.
B
BDPTBioadaptives, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.16K$1.16Kderivedno prior Q4 2018 on file Net Income-$96.60K-$96.60KderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioadaptives, Inc. · CIK 1575142 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$1,635— Operating Cash Flowderived-$76,400— Margins · derivedGross margin-141.6%
Net margin-8363.3%
ended Dec 31, 2019 · filed May 1, 2020 · 122 d after period end